» Articles » PMID: 24828189

Nucleotide Signalling During Inflammation

Overview
Journal Nature
Specialty Science
Date 2014 May 16
PMID 24828189
Citations 451
Authors
Affiliations
Soon will be listed here.
Abstract

Inflammatory conditions are associated with the extracellular release of nucleotides, particularly ATP. In the extracellular compartment, ATP predominantly functions as a signalling molecule through the activation of purinergic P2 receptors. Metabotropic P2Y receptors are G-protein-coupled, whereas ionotropic P2X receptors are ATP-gated ion channels. Here we discuss how signalling events through P2 receptors alter the outcomes of inflammatory or infectious diseases. Recent studies implicate a role for P2X/P2Y signalling in mounting appropriate inflammatory responses critical for host defence against invading pathogens or tumours. Conversely, P2X/P2Y signalling can promote chronic inflammation during ischaemia and reperfusion injury, inflammatory bowel disease or acute and chronic diseases of the lungs. Although nucleotide signalling has been used clinically in patients before, research indicates an expanding field of opportunities for specifically targeting individual P2 receptors for the treatment of inflammatory or infectious diseases.

Citing Articles

Glial cell line-derived neurotrophic factor improves impaired colonic motility in experimental colitis mice through connexin 43.

Yang W, Liu R, Xu F World J Gastroenterol. 2025; 31(8):100069.

PMID: 40062335 PMC: 11886518. DOI: 10.3748/wjg.v31.i8.100069.


P2RX1 in neutrophils mediates JAK/STAT signaling pathway to regulate malignant phenotype of gastric Cancer cells.

Zhang Y, Zhang F, Liu Z, Li M, Wu G, Li H Mol Genet Genomics. 2025; 300(1):23.

PMID: 39985719 DOI: 10.1007/s00438-025-02227-9.


The vasoconstrictor adenosine 5'-tetraphosphate is a danger signal that induces IL-1β.

Bockstiegel J, Engelhardt J, Schuchardt M, Tolle M, Weindl G Mol Med. 2025; 31(1):72.

PMID: 39984847 PMC: 11844157. DOI: 10.1186/s10020-025-01116-6.


P2X7R antagonism suppresses long-lasting brain hyperexcitability following traumatic brain injury in mice.

Alves M, de Diego-Garcia L, Vegliante G, Moreno O, Gil B, Ramos-Cabrer P Theranostics. 2025; 15(4):1399-1419.

PMID: 39886340 PMC: 11780721. DOI: 10.7150/thno.97254.


Lipopolysaccharide-Neutralizing Peptide Modulates P2X7 Receptor-Mediated Interleukin-1β Release.

Engelhardt J, Klawonn A, Dobbelstein A, Abdelrahman A, Oldenburg J, Brandenburg K ACS Pharmacol Transl Sci. 2025; 8(1):136-145.

PMID: 39816791 PMC: 11729421. DOI: 10.1021/acsptsci.4c00496.


References
1.
Ghiringhelli F, Apetoh L, Tesniere A, Aymeric L, Ma Y, Ortiz C . Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors. Nat Med. 2009; 15(10):1170-8. DOI: 10.1038/nm.2028. View

2.
Sansom F, Newton H, Crikis S, Cianciotto N, Cowan P, dApice A . A bacterial ecto-triphosphate diphosphohydrolase similar to human CD39 is essential for intracellular multiplication of Legionella pneumophila. Cell Microbiol. 2007; 9(8):1922-35. DOI: 10.1111/j.1462-5822.2007.00924.x. View

3.
Weber F, Esser P, Muller T, Ganesan J, Pellegatti P, Simon M . Lack of the purinergic receptor P2X(7) results in resistance to contact hypersensitivity. J Exp Med. 2010; 207(12):2609-19. PMC: 2989767. DOI: 10.1084/jem.20092489. View

4.
Soulet C, Sauzeau V, Plantavid M, Herbert J, Pacaud P, Payrastre B . Gi-dependent and -independent mechanisms downstream of the P2Y12 ADP-receptor. J Thromb Haemost. 2004; 2(1):135-46. DOI: 10.1111/j.1538-7836.2004.00556.x. View

5.
Idzko M, Panther E, Sorichter S, Herouy Y, Berod L, Geissler M . Characterization of the biological activities of uridine diphosphate in human dendritic cells: Influence on chemotaxis and CXCL8 release. J Cell Physiol. 2004; 201(2):286-93. DOI: 10.1002/jcp.20070. View